Tilray CEO: Alternatives in clinical cannabis are gargantuan
Tilray’s inventory is up this day, however aloof down 80 percent from a February excessive. CNBC’s Frank Holland experiences on his conversation with Tilray CEO Irwin Simon regarding the firm’s…